Finance Report 2020
Excerpt from the
58th Annual Report 2020/2021
EMS-CHEMIE HOLDING AG
Domat/Ems Switzerland
Content
EMS Group | Share Performance | 3 |
Key Figures 2016 - 2020 | 4 | |
Remuneration Report | 5 | |
Report of the Statutory Auditor on | ||
the Remuneration Report | 6 | |
Consolidated Income Statement | 7 | |
Consolidated Balance Sheet | 8 | |
Consolidated Statement of Changes in Equity | 9 | |
Consolidated Statement of Cash Flows | 10 | |
Notes to the Consolidated Financial Statements | 11 - 42 | |
Report of the Statutory Auditor on | ||
the Consolidated Financial Statements | 43 - 45 |
EMS-CHEMIE HOLDING AG
Data for the Financial Year May 1, 2020 - April 30, 2021
Income Statement | 47 |
Balance Sheet | 48 |
Notes to the Financial Statements | 49 - 52 |
Proposed appropriation of available earnings | 52 |
Report of the Statutory Auditor on the | |
Financial Statements | 53 - 54 |
EMS Group Share Performance
Annual Report 2020/2021
2020 | 2019 | 2018 | 2017 | 2016 | |||
Number of registered shares | 23 389 028 | 23 389 028 | 23 389 028 | 23 389 028 | 23 389 028 | ||
Shares entitled to dividend | 23 389 028 | 23 389 028 | 23 389 028 | 23 389 028 | 23 381 277 | ||
Treasury shares | 0 | 0 | 0 | 0 | 7 751 | ||
Information per share (in CHF): | |||||||
Dividend per share | 17.00 1) | 20.00 | 19.75 | 18.50 | 17.00 | ||
Of which ordinary dividend | 13.00 | 15.60 | 15.50 | 14.50 | 13.00 | ||
Of which extraordinary dividend | 4.00 | 4.40 | 4.25 | 4.00 | 4.00 | ||
Earnings per share | 18.57 | 22.54 | 22.22 | 20.59 | 19.19 | ||
Cash flow per share 2) | 21.12 | 25.01 | 24.61 | 22.98 | 21.89 | ||
Equity per share 3) | 68.32 | 71.09 | 69.48 | 65.20 | 60.09 | ||
Stock prices 4) | |||||||
High | 880.00 | 646.50 | 691.00 | 707.00 | 547.50 | ||
Low | 496.60 | 458.00 | 447.60 | 508.00 | 404.50 | ||
At December 31 | 853.00 | 636.50 | 467.00 | 650.50 | 517.50 | ||
Market capitalisation on December 31 (CHF millions) | 19 950.8 | 14 887.1 | 10 922.7 | 15 214.6 | 12 103.8 |
Registered shares are listed on the SIX Swiss Exchange. | |||
Security number | ISIN | Investdata/Reuters | |
EMS-CHEMIE | 1.644.035 | CH0016440353 | EMSN |
- Proposal of the Board of Directors.
- Cash flow = net income plus write-downs on intangible assets, property, plant and equipment plus value adjustments to securities.
- Excluding non-controlling interests.
- Source: SIX Swiss Exchange AG.
3
Key Figures 2016 - 2020
CHF millions | 2020 | 2019 | 2018 | 2017 | 2016 |
Net sales revenue | 1 802.3 | 2 152.7 | 2 318.3 | 2 145.8 | 1 983.1 |
Change in % against previous year | −16.3 % | −7.1 % | +8.0 % | +8.2 % | +4.1% |
EMS Group
Annual Report 2020/2021
Change in local currencies | −4.8 % | −2.1 % | +6.4 % | +7.5 % | +3.8 % | |||
Of which in Switzerland | 4.0 % | 3.7 % | 3.4 % | 3.2 % | 3.1 % | |||
Net operating income (EBIT) | 515.1 | 623.7 | 620.2 | 582.0 | 547.7 | |||
Change in % against previous year | −17.4 % | +0.6 % | +6.6 % | +6.3 % | +16.9 % | |||
In % of net sales revenue | 28.6 % | 29.0 % | 26.8 % | 27.1 % | 27.6 % | |||
Net financial income | −4.4 | −3.5 | −2.0 | 0.9 | −5.2 | |||
Income taxes | 71.1 | 88.4 | 95.8 | 98.5 | 86.9 | |||
Net income | 439.7 | 531.9 | 522.3 | 484.4 | 455.5 | |||
Change in % against previous year | −17.3 % | +1.8 % | +7.8 % | +6.3 % | +19.0 % | |||
In % of net sales revenue | 24.4 % | 24.7 % | 22.5 % | 22.6 % | 23.0 % | |||
Cash flow 1) | 494.0 | 584.9 | 575.5 | 537.4 | 511.8 | |||
Change in % against previous year | −15.5 % | +1.6 % | +7.1 % | +5.0 % | +16.6 % | |||
In % of net sales revenue | 27.4 % | 27.2 % | 24.8 % | 25.0 % | 25.8 % | |||
Investments | 48.3 | 62.9 | 60.2 | 49.3 | 71.5 | |||
In % of cash flow | 9.8 % | 10.8 % | 10.5 % | 9.2 % | 14.0 % | |||
Balance sheet total | 2 077.5 | 2 213.3 | 2 157.6 | 2 100.0 | 1 984.6 | |||
Assets | ||||||||
Current assets | 1 399.5 | 1 547.7 | 1 517.9 | 1 460.4 | 1 337.5 | |||
Non-current assets | 678.0 | 665.6 | 639.7 | 639.6 | 647.1 | |||
Equity and liabilities | ||||||||
Current liabilities | 290.7 | 351.9 | 365.2 | 390.6 | 366.6 | |||
Non-current liabilities | 162.6 | 175.8 | 147.8 | 158.9 | 190.2 | |||
Equity 2) | 1 597.8 | 1 662.7 | 1 625.1 | 1 525.0 | 1 405.0 | |||
Balance sheet equity ratio | 76.9 % | 75.1 % | 75.3 % | 72.6 % | 70.8 % | |||
Return on equity | 27.2 % | 31.7 % | 32.0 % | 31.6 % | 31.9 % | |||
Number of employees on December 313) | 2 521 | 2 648 | 2 939 | 2 912 | 2 897 | |||
- Cash flow = net income plus write-downs on intangible assets, property, plant and equipment plus value adjustments to securities.
- Excluding non-controlling interests.
- Excluding apprentices (2020: 132; 2019: 129; 2018: 136; 2017: 138; 2016: 144).
4
EMS Group Annual Report 2020/2021
Remuneration Report
Remuneration system, competence and method of determining
The remuneration system for members of the Board of Directors and Executive Management consists, as per the Articles of Association, of a fixed remuneration and a possible variable remuneration component, which are paid out in cash only.
EMS has no participation plan. The fixed and any possible variable remuneration component are independent of each other. The variable remuneration component may form a central part of the overall remuneration package. The principle criteria for the variable remuneration component are the achievement of earnings targets and
project objectives. The Board of Directors determines the variable remuneration component at its discretion taking target achievement into account.
The remuneration sum is defined by the Board of Directors at the proposal of the Remuneration Committee and after consultation with the CEO. Variable remuneration components are paid in May of the following year. According to the current contracts, members of the Board of Directors only receive a fixed remuneration. In the reporting year, the variable remuneration component of members of Executive Management amounts on average to 40 % of the total remune ration sum (2019/2020: 41 %).
Remuneration for the reporting period and comparison with previous period (audited by the Statutory Auditors)
The following remuneration was paid in the reporting year (1.5.2020 - 30. 4.2021):
2020/2021 | 2019/2020 | ||
(CHF '000) | (CHF '000) | ||
Board of Directors | Function | Remuneration | |
Dr U. Berg | Chairman (until 8.8.2020) | 175 | 242 |
B. Merki | Chairman (since 9.8.2020) | 154 | 137 |
M. Martullo | Vice-Chairman and CEO | 242 | 239 |
Dr J. Streu | Member | 125 | 130 |
Ch. Mäder | Member | 137 | 150 |
Total Board of Directors | 833 | 898 | |
Executive Management | |||
Total remuneration paid to the Executive Management was | 2 829 | 2 777 | |
Of this, KCHF 1 136 (2019/2020: KCHF 1 146) was variable remuneration | |||
components. The highest remuneration for a member of Executive Management | |||
in the reporting year was KCHF 1 033 (2019/2020: KCHF 1 024) and of | |||
this, KCHF 523 (2019/2020: KCHF 523) as variable remuneration compo- | |||
nent, paid to M. Martullo, independent of her remuneration as Member of the | |||
Board of Directors. | |||
Total remuneration paid to the Board of Directors and Executive Management was | 3 662 | 3 675 | |
The remuneration is paid exclusively in cash. | |||
EMS has no stock option program. | |||
Advisory board | There is no advisory board. |
No remuneration was paid to former members of the Board of Directors or Executive Management in connection with any earlier function within the company. Furthermore, all remuneration for current or former members of the Board of Directors, Executive Management and related parties was paid based on standard market terms. Due to the COVID 19 pandemic, the Board of Directors and Executive Management of EMS voluntarily took a 15 % reduction in fees and fixed salaries for 7 months in 2020 as a sign of solidarity. During the year, the personal composition of the Executive Board changed.
5
Attachments
- Original document
- Permalink
Disclaimer
EMS-Chemie Holding AG published this content on 12 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 July 2021 06:42:02 UTC.